VRNA - Verona Pharma PLC Net earnings per share (EPS TTM)

Symbol and logo of brand Verona Pharma PLC (VRNA)

A snapshot of the rolling net income per share helps assess the effectiveness of Verona Pharma plc (VRNA) strategic alliances for developing respiratory medications. Business resilience is bolstered by rigorous pharmaceutical logistics and patents for the Ensifentse drug used in COPD therapy. This indicator reveals hidden risks of developmental stagnation, with the metric currently standing at -1.04, eliminating mathematical reporting distortions.

VRNA (Verona Pharma plc) Net earnings per one share for the last twelve months history from 07/04/2022 to 10/18/2025

Verona Pharma Corp - analytical breakdowns and key metrics (VRNA)

- share price and expert price forecast:
Basic company analysis:VRNA - Verona Pharma
Flagship merchandise of Verona Pharma PLC

Net income per share over twelve months measures the equity portion of the bottom line, allowing investors to filter out market volatility and assess the actual efficiency of the business. By analyzing the 12-month EPS trend, an investor can forecast the growth in value of Verona Pharma plc (VRNA), leveraging the high margins of Ohtuvayre, which is protected from generics by strict patent barriers and FDA approval.

Competing companies

Haleon - Net earnings per share (EPS TTM)|Kenvue - Earnings per share for the last four quarters|MENS: Net earnings per share (EPS TTM)|Ligand Pharma - Earnings per share for the trailing year|AMRX (Amneal Pharmaceuticals, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months perrigo.com PRGO|Earnings per share for the last twelve months Alvotech SA (ALVO)|LQDA (Liquidia Corp) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) GLPG (Galapagos N.V.)|Net earnings per share (EPS TTM) ANI Pharmaceuticals Corp ANIP|Afrezza - Net earnings per share (EPS TTM)|amphastar.com (AMPH) - Net earnings per share for the last 12 months|PCRX: Net earnings per share (EPS TTM)|SPRY - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Theravance|Net earnings per one share for the last twelve months Aquestive Corp AQST|Net earnings per share (EPS TTM) SCPH|TECX - Net earnings per one share for the last twelve months|Tonix Pharmaceuticals Holding Corp. - Net earnings per share for the last 12 months|Earnings per share for the trailing year SXTC|Eupraxia Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|BHST: Earnings per share for the last twelve months|invizyne.com (EXOZ) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ORMP (Oramed)|ENTX (Entera Bio) - Net earnings per share (EPS TTM)|HYFT: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC|Cumberland Pharmaceuticals - Earnings per share for the last 12 months|Earnings per share for the last twelve months Quantum BioPharma Ltd. QNTM|FGEN: Earnings per share for the last 12 months|TELO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Rani Therapeutics Holdings|SNYR: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RLYB (Rallybio Corp.)|LEXX (Lexaria Bioscience Corp.) - Net earnings per share (EPS TTM)|pulmatrix.com (PULM) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pheton (PTHL)|Net earnings per share for the last four quarters Aptorum Group Ltd|Net earnings per share (EPS TTM) LYRA (Lyra Therapeutics Inc)|Impact BioMedical - Earnings per share for the last twelve months|TNF Pharmaceuticals - Net earnings per share (EPS TTM)|YCBD - Net earnings per share (EPS TTM)|PRFX: Net earnings per share (EPS TTM)|CYTO: Earnings per share for the last four quarters|LIPO (Lipella Pharma) - Net earnings per share (EPS TTM)|OPTN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PIRS|PROC (procapsgroup.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Petros Pharmaceuticals, Inc. PTPI|Qilian International Holding - Earnings per share for the last twelve months|SLRN - Earnings per share for the last twelve months|Earnings per one share for the last 12 months TFFP